| Serial Number | 86613156 |
| Word Mark | NANOPARTICLE DRUG CONJUGATES |
| Filing Date | Tuesday, April 28, 2015 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Friday, May 5, 2017 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | pharmaceutical preparations and substances for diagnosis and targeted treatment of cancer and tumor diseases; pharmaceutical preparations and substances for diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; therapeutic agents for diagnosis and targeted treatment of cancer and tumor diseases; therapeutic agents for diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; therapeutic pharmaceuticals and substances for the diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations and substances for diagnosis and treatment of diseases and disorders; therapeutic agents for diagnosis and treatment of diseases and disorders |
| Goods and Services | research and development in the fields of pharmaceuticals, biotechnology, therapeutics, and drug formulation and delivery; research and development in the field of targeted therapies for cancer and tumor diseases; research and development in the field of targeted therapies for viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; consulting services in the field of scientific research; consulting services in the field of research and development for pharmaceuticals, biotechnology, therapeutics, and drug formulation and delivery; consulting services in the field of clinical trials; testing, inspection, research, or development of pharmaceutical and therapeutic preparations; pharmaceutical and therapeutic drug development services; pharmaceutical and therapeutic product evaluation; conducting early evaluations in the field of new pharmaceuticals and therapeutics; conducting quality control testing, feasibility testing, toxicology testing and pharmacology testing for pharmaceuticals and therapeutics; laboratory research services relating to pharmaceuticals and therapeutics; medical and scientific research, namely, conducting clinical trials for others; product safety testing for pharmaceuticals and therapeutics |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, May 9, 2015 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 7 - Inactive - Insufficient fee received |
| Class Status Date | Saturday, May 9, 2015 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Memorial Sloan Kettering Cancer Center |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | New York, NY 10065 |
| Event Date | Event Description |
| Friday, May 5, 2017 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Friday, May 5, 2017 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Friday, October 7, 2016 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, October 7, 2016 | FINAL REFUSAL E-MAILED |
| Friday, October 7, 2016 | FINAL REFUSAL WRITTEN |
| Friday, September 16, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, September 16, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, September 10, 2016 | ASSIGNED TO LIE |
| Friday, September 2, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 4, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, March 4, 2016 | NON-FINAL ACTION E-MAILED |
| Friday, March 4, 2016 | NON-FINAL ACTION WRITTEN |
| Friday, February 12, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, February 11, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 11, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, August 12, 2015 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, August 12, 2015 | NON-FINAL ACTION E-MAILED |
| Wednesday, August 12, 2015 | NON-FINAL ACTION WRITTEN |
| Thursday, August 6, 2015 | ASSIGNED TO EXAMINER |
| Saturday, May 9, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, May 1, 2015 | NEW APPLICATION ENTERED IN TRAM |